Cencora, Inc. (1COR)
MTA
Closed
Aug 21, 2026
Day's Range
279.6052 wk Range
213.30Overview - 1COR - Cencora, Inc.
Key Statistics
Valuation
Enterprise Value
54.72B
P/E (Trailing)
‪23.75‬
PEG Ratio
‪2.10‬
Price / Sales (TTM)
‪0.15‬
Price / Book
‪20.00‬
EV / EBITDA
‪11.54‬
Profitability
Gross Margin
‪4.25%‬
Profit Margin
‪0.78%‬
Operating Margin
‪1.41%‬
Return on Assets
‪3.55%‬
Return on Equity
‪96.87%‬
Ownership
Shares Outstanding
190.82M
Float
180.23M
Held by Insiders
‪4.30%‬
Held by Institutions
‪99.59%‬
Price stats
Beta
‪0.57‬
50-Day Avg
‪253.53‬
200-Day Avg
‪278.26‬
Dividends
Payout Ratio
‪17.45%‬
Frequency
Quarterly
Market Cap - 1COR - Cencora, Inc.
Peers - 1COR - Cencora, Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on MTA.
Profile Summary - 1COR - Cencora, Inc.
About
Cencora, Inc. is a global pharmaceutical solutions organization that serves as a critical link between drug manufacturers, healthcare providers, pharmacies, and patients. Headquartered in Conshohocken, Pennsylvania, Cencora focuses on sourcing and distributing branded, generic, and specialty pharmaceutical products,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
